🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
Study on the therapeutic effect of different infusion times on tislelizumab...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
Start Date
2025-12-01
Trial ID
NCT07243691
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-04-01
Trial ID
NCT07531979
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This is a prospective, open, multiple-center clinical study of renal preser...
Status
Recruiting
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-06-10
Trial ID
NCT05912816
Treatments Being Tested
This is an open-label, non-randomized, multicenter, Phase 1/2a study to eva...
Status
Terminated
Location
Rambam Medical Center
Start Date
2022-11-15
Trial ID
NCT05581719
Treatments Being Tested
This is a prospective, open, single-center clinical study of anti-HER2-ADC ...
Status
Unknown
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-08-05
Trial ID
NCT05957757
Treatments Being Tested
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580